Skip to main content
Opens in new window
NHS Wales
Health Boards
Trusts
NHS 111 Wales
Skip Navigation
Accessibility Statement
Cymraeg
Cymraeg
All...
Search
Velindre University NHS Trust
Search
Cymraeg
Cymraeg
Menu
Home
Destination 2033
Show Submenu For Destination 2033
Who we are and what we do...
Why do we need a new strategy?
How we will achieve our vision
About us
Show Submenu For About us
How we work
Publications
Trust Board
Working for the Trust
Duty of Quality
Public engagement | Formal consultation
Our values
News
Show Submenu For News
Latest News
Contact
Show Submenu For Contact
General Enquiries
Feedback
Duty of Candour
Concerns and complaints
Treatment helpline
Media Enquiries
Social Media
Topics
Show Submenu For Topics
Cost of living
COVID-19
Healthcare Acquired Infections
Mental health
Welsh Blood Service
Velindre Cancer Service
Show Submenu For Velindre Cancer Service
Inpatients
Outpatients
Patient Information
Contact
Treatment helpline
Our services
Directories
Getting to Velindre
Visiting
Engage with us
new Velindre Cancer Centre
Radiotherapy Unit at Nevill Hall Hospital
Charity
More
×
NHS Wales
Health Boards
Trusts
NHS 111 Wales
Accessibility Statement
All...
Search
Home
›
About us
›
Publications
›
Freedom of information
›
FOIA - Disclosure Logs 2024
›
October 2024
›
CORP 2024 - 200 Usage of Medicines in Secondary Care
CORP 2024 - 200 Usage of Medicines in Secondary Care
23/01/2025
CORP 2024 - 200 Usage of Medicines in Secondary Care
23/01/2025
CORP 2024 - 200 - Usage of Medicines in Secondary Care
